Aplasia medular asociada al uso de ticlopidina / Bone marrow aplasia associated to the use of ticlopidine: report of one case
Rev. méd. Chile
; 130(7): 798-802, jul. 2002. tab, graf
Article
de Es
| LILACS
| ID: lil-323256
Bibliothèque responsable:
CL1.1
RESUMO
We report a 58 years old male that developed a bone marrow aplasia associated to the use of ticlopidine, prescribed after coronary artery stenting. The patient developed a pneumonia as a complication. He was admitted to the Intermediate Treatment Unit, receiving wide spectrum antimicrobial therapy and a granulocyte colony stimulating factor (Neupogen(r)) with favourable response. Ticlodipine is an effective anti-platelet agent, but has serious hematological and other side effects. Its prescription requires a close follow up and search for complications
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Maladies de la moelle osseuse
/
Ticlopidine
Type d'étude:
Risk_factors_studies
Limites du sujet:
Humans
/
Male
langue:
Es
Texte intégral:
Rev. méd. Chile
Thème du journal:
MEDICINA
Année:
2002
Type:
Article